Problems related to high-dose estrogen/progestogen combinations, such as Menstrogen, in India
Van Keep, P.A.
Nederlands Tijdschrift Voor Geneeskunde 132(8): 364-365
1988
ISSN/ISBN: 0028-2162 PMID: 3362255 Document Number: 374679
Document emailed within 1 workday
Related Documents
Wolffers, I. 1988: Problems with high-dose estrogen/progestin combinations such as Mestrogen, in India Nederlands Tijdschrift Voor Geneeskunde 132(1): 29-31Hertz, R.; Bailar, J.C. 1966: Estrogen-progestogen combinations for contraception JAMA 198(9): 1000-1006
Sartoretto, J.N.; Ortega-Recio, J.C.; Moraes, R.; Filho, F.N. 1977: Clinical studies with a low dose estrogen-progestogen combination Contraception 15(5): 563-570
Lin, S.Q. 1990: Action of low-dose estrogen and progestogen on the relief of climacteric symptoms and excretion of urinary calcium Zhonghua Fu Chan Ke Za Zhi 25(4): 198-201; 251
Takano, N.; Kimura, J.; Okada, H. 1982: Defective estrogen receptor in uteri of rats treated neonatally with a high dose of estrogen Nihon Sanka Fujinka Gakkai Zasshi 34(3): 391-395
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Andreoli, C.; Fiorentino, F.; Lenzi, G. 1970: Clinical experience with an estrogen-progestogen association with low estrogen content (ethinodiol-ethinylestradiol) Quaderni di Clinica Ostetrica E Ginecologica 25(1): 15-28
Mort, J.R. 2008: High dose acetaminophen in narcotic combinations: should there be concern? South Dakota Medicine: the Journal of the South Dakota State Medical Association 61(8): 294-295
Hemanth Kumar, A.K.; Ramachandran, G.; Rajasekaran, S.; Padmapriyadarsini, C.; Narendran, G.; Anitha, S.; Subramanyam, S.; Kumaraswami, V.; Swaminathan, S. 2009: Pharmacokinetics of lamivudine and stavudine in generic fixed-dose combinations in HIV-1 infected adults in India Indian Journal of Medical Research 130(4): 451-457
Sabra, A.; Bonnar, J. 1983: Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel Journal of Reproductive Medicine 28(1 Suppl): 85-91
Capizzi, R.L.; Yang, J.L.; Rathmell, J.P.; White, J.C.; Cheng, E.; Cheng, Y.C.; Kute, T. 1985: Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation Seminars in Oncology 12(2 Suppl 3: 65-74
Hayashi, T.; Taki, Y.; Ikai, K.; Hiura, M.; Kiriyama, T. 1987: Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen Hinyokika Kiyo. Acta Urologica Japonica 33(7): 1035-1042
Sturtevant, F.; Wait, R.B. 1970: High-dose estrogen sequential oral contraception I. Effectiveness assessed by the life table technique Contraception 2(3): 187-191
Briggs, M.; Briggs, M. 1983: Oral contraceptives containing estrogen plus progestogen Benagiano, G And E Diczfalusy (Ed ) Comprehensive Endocrinology: Endocrine Mechanisms in Fertility Regulation Xi+354p Raven Press: New York, N Y , Usa Illus P17-48
D'arcangues, C. 1991: Once-a-month estrogen/progestogen injectables Entre Nous 19: 15
Check, J.H.; Adelson, H.G. 1984: Improvement of cervical factor by high-dose estrogen and human menopausal gonadotropin therapy with ultrasound monitoring Obstetrics and Gynecology 63(2): 179-181